相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Five-Year Outcomes From the Randomized, Phase III Trials CheckMate O17 and O57: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer (vol 39, pg 723, 2021)
Borghaei
JOURNAL OF CLINICAL ONCOLOGY (2021)
Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study
Diego Kauffmann-Guerrero et al.
SCIENTIFIC REPORTS (2021)
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Hossein Borghaei et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab
Ou Yamaguchi et al.
THORACIC CANCER (2021)
Chronic obstructive pulmonary disease and lung cancer incidence in never smokers: a cohort study
Hye Yun Park et al.
THORAX (2020)
Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort
Mamta Ruparel et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pulmonary function is implicated in the prognosis of metastatic non-small cell lung cancer but not in extended disease small cell lung cancer
Suk-Young Lee et al.
JOURNAL OF THORACIC DISEASE (2019)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Satya Das et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade
Jerome Biton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab
Yukihiro Toi et al.
ONCOLOGIST (2018)
A lower level of forced expiratory volume in one second predicts the poor prognosis of small cell lung cancer
Hye Seon Kang et al.
JOURNAL OF THORACIC DISEASE (2018)
Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients
Kimitaka Akaike et al.
ANTICANCER RESEARCH (2018)
Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application
Nancy Tray et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review
Hanbo Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lung cancer in patients with idiopathic pulmonary fibrosis
Theodoros Karampitsakos et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Impact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studies
Yong-hua Gao et al.
RESPIROLOGY (2016)
Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes
Valerie Siroux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
FEV1 Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study
Ana Maria B. Menezes et al.
PLOS ONE (2014)
A Lower Level of Forced Expiratory Volume in 1 Second Is a Risk Factor for All-Cause and Cardiovascular Mortality in a Japanese Population: The Takahata Study
Yoko Shibata et al.
PLOS ONE (2013)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Forced Expiratory Volume in One Second as a Prognostic Factor in Advanced Non-small Cell Lung Cancer
Jin Hwa Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
The Pathology of Chronic Obstructive Pulmonary Disease
James C. Hogg et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study
W. M. Vollmer et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Association of radiographic emphysema and airflow obstruction with lung cancer
David O. Wilson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes
R. P. Young et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers
Michelle C. Turner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers
Mark P. Purdue et al.
THORAX (2007)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
The epidemiology of interstitial lung disease and its association with lung cancer
G Raghu et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
